Training Example: REMICADE® (Johnson & Johnson) – Review the Data, Give Your Score & Compare to the Real AI Evaluation

Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…

REMICADE® (Johnson & Johnson)

(https://remicade.com) 📸 Data Snapshot: June 19, 2026

Analyze the raw signals below. How would a machine score this business’s credibility?

Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.

🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Official Consumer Website for REMICADE® (infliximab) | REMICADE® (https://remicade.com)
Title

Official Consumer Website for REMICADE® (infliximab) | REMICADE®

Meta

Learn about treatment with REMICADE® across all uses on the official patient website. See full Product & Safety Info, including Boxed Warnings.

H2 I am CURRENTLY being treated with REMICADE®
H2 I am starting treatment with REMICADE®
H2 Patient resources
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://remicade.com) Official Consumer Website for REMICADE® (infliximab) | REMICADE®
[H2] I am CURRENTLY being treated with REMICADE®
Your treatment choice. Being asked to switch. Support to stay on therapy.
Get information

[H2] I am starting treatment with REMICADE®
Learn about REMICADE®. How REMICADE® works. Paying for therapy.

Learn more
Adult: moderately to severely active Crohn’s disease
Pediatric: moderately to severely active Crohn's disease
Adult: moderately to severely active ulcerative colitis
Pediatric: moderately to severely active ulcerative colitis
Adult: moderately to severely active rheumatoid arthritis
Adult: active psoriatic arthritis
Adult: active ankylosing spondylitis
Adult: chronic severe plaque psoriasis

[H2] Patient resources

[IMG: Money Icon]

Find cost support options to help make treatment more affordable.

LEARN ABOUT COST SUPPORT OPTIONS

[IMG: Headset Icon]

See how our J&J withMe Care Coordinators can help you start, stay, and save on REMICADE®.

Customized support from a J&J withMe care coordinator

[IMG: Location Icon]

See treatment locations that are close to your home or workplace.

Find an infusion center

[IMG: Magazine Icon]

Get more information about REMICADE® and listen to other patients describe their treatment experiences.

Resources for you
1289 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
0Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 0 0
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage — no schema detected (entity gap)

Your Diagnosis

Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.

Information Density 0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence 0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof 0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint 0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority 0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score 0 / 100
💡 Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)

These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.

Information Density

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Semantic Alignment

Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.

Trust & Proof

Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.

Commodity Fingerprint

Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.

Identity & Authority

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: REMICADE® (Johnson & Johnson) (remicade.com)

https://remicade.com 📍 Industry: Medical Devices, Pharma & Biotech
12 BS / 100

This is a high-substance, low-BS pharmaceutical site that prioritizes regulatory compliance and patient navigation over marketing hyperbole. It functions as a tool rather than a pitch, anchored by clinical specificity and clear pathways to care. The only ‘BS’ present is the unavoidable boilerplate language required by the pharmaceutical industry’s service models.

Info Density Power-words vs. Substance ratio.
3
10% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
0
0% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
1
5% BS
Commodity Fingerprint Detection of industry clichés/templates.
2
13% BS
Identity & Authority Expert verifiability & Schema depth.
6
40% BS

Implement a clear H1 tag such as ‘REMICADE® (infliximab) Patient Support and Treatment Information’ to improve technical hierarchy. Deploy comprehensive Product and MedicalOrganization schema_json to link the brand to its FDA regulatory filings. Explicitly cite the most recent clinical trial data or ‘last updated’ dates for the patient resource magazine to ensure temporal relevance. Provide direct outbound links to peer-reviewed studies for each of the eight listed indications on the homepage.

The content perfectly aligns with the Pharma & Biotech industry, specifically focusing on a biologic therapy (infliximab) for autoimmune conditions. The presence of ‘Boxed Warnings’ and specific FDA-approved indications like ‘moderately to severely active Crohn’s disease’ confirms this classification.

“The score of 12 is driven primarily by technical gaps (Identity and Authority) and minor industry template markers. The Information Density and Semantic Coherence pillars scored near zero for BS because the content is almost entirely composed of specific medical indications and functional patient pathways. The site successfully avoids the 'breakthrough innovation' clichés common in the industry dictionary.”

Verified Analysis Date: June 19, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result